Product Description
ANASTROZOLE TABLETS IP 1MG, a celebrated non-steroidal aromatase inhibitor, is offered in a highlighted blister or strip pack, strictly for prescription clearance through registered oncologists. Eminent for its optimum efficacy in hormonal therapy for postmenopausal breast cancer patients, each round, film-coated, sugar-free tablet contains 1 mg Anastrozole. This renowned medication acts by inhibiting aromatase enzyme activity, essential for estrogen suppression in oncology treatments. Accompanied by side effects like hot flushes and headache, its contraindicated in pregnancy and premenopausal women. Store below 30C. Available for distributors, suppliers, and exporters across India.
Application Spectrum and Usage Method for ANASTROZOLE TABLETS IP 1MG
ANASTROZOLE TABLETS IP 1MG is widely employed in oncology, especially for hormonal therapy in postmenopausal women diagnosed with breast cancer. The optimum application method is an oral route, with each tablet to be consumed as per oncologists direction. Administered with water, it can be integrated into most daily regimens. The celebrated efficacy is attributed to its precise enzyme inhibitor activity, making it eminent among prescription oral therapies in specialized oncology application media.
Export, FOB Port, and Certifications: Delivery Excellence
We ensure express shipping of ANASTROZOLE TABLETS IP 1MG from Indias leading FOB ports to main export markets including Asia, Africa, and the Middle East. Each batch arrives with necessary certifications, ensuring quality and regulatory compliance. Delivery options are available for authorized traders, distributors, and wholesalers. We offer an efficient order exchange process, emphasizing reliable clearance and international standards for oncology treatments, all while maintaining a consistent supply for global recipient markets.
FAQs of ANASTROZOLE TABLETS IP 1MG:
Q: How should ANASTROZOLE TABLETS IP 1MG be taken for optimum results?
A: ANASTROZOLE TABLETS IP 1MG should be swallowed whole with water, once daily, precisely as prescribed by an oncologist. Adhering to your physicians instructions maximizes treatment efficacy and reduces unwanted side effects.
Q: What are the main application areas of ANASTROZOLE TABLETS IP 1MG?
A: This medication is primarily indicated for hormonal therapy in postmenopausal women diagnosed with breast cancer, operating as an aromatase inhibitor in specialized oncology treatments.
Q: When is ANASTROZOLE TABLETS IP 1MG contraindicated?
A: Use of this product is contraindicated in pregnancy and in premenopausal women, as its primary indication and safety data are designated for postmenopausal patients only.
Q: Where should ANASTROZOLE TABLETS IP 1MG be stored to maintain optimum potency?
A: Store the medication below 30C in a place protected from light and moisture to ensure the tablets remain stable and effective throughout their shelf life.
Q: What process ensures the clearance and authenticity of ANASTROZOLE TABLETS IP 1MG for export?
A: Every batch is backed by certifications and undergoes stringent quality checks, ensuring only authorized wholesalers, distributors, and traders receive genuine, cleared pharmaceutical shipments.
Q: What are common side effects associated with the usage of ANASTROZOLE TABLETS IP 1MG?
A: Typical side effects may include hot flushes, headache, joint pain, and weakness. Any severe or persistent symptoms should be promptly discussed with your healthcare provider.